semaglutide cancer cases glp-1 risk No Increased for Thyroid in Diabetic Patients Prescribed Medications Compared to Those Prescribed Insulin Semaglutide: What we know about – Current evidence suggests GLP1-RA diabetes

Speak with your healthcare provider to understand whats realistic for you

Choose Your Microdose Microdose Semaglutide GLP-1 Injectable Personalized by Provider Potential benefits* Single GLP Agonist Support* Supports Healthy Blood Sugar Balance* Enhanced Inflammatory Response* Reduce Food Noise & Cravings* Supports Brain Health & Mental Clarity* May Aid in Weight Management During Hormonal Shifts* Start Your Intake Form Microdose Tirzepatide GLP-1/GIP Injectable Clinician guided Potential benefits* Dual GLP Agonist Support* Stronger Blood Sugar Balance* Helps Reduce Inflammation* Stronger Reduction of Food Noise & Cravings* Supports Brain Health & Mental Clarity* May Aid in Weight Management During Hormonal Shifts Start Your Intake Form *Statements are general educational information and are not medical advice

Active Ingredient: Tirzepatide The active ingredient, Tirzepatide, is a dual agonist it activates GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors

The most alarming negative reviews involve the purchasing experience itself

Ozempic: Whats the Difference

Some researchers prefer a 3 mL or 5 mL mixing syringe for this step, then switch to insulin syringes for dose withdrawals